Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Aclaris Therapeutics, Inc. (ACRS) had Weighted-Average Shares Outstanding (Basic) of 77.30M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$18.72M |
|
$-132.06M |
|
$15.46M |
|
$3.26M |
|
$160.65M |
|
$-141.93M |
|
$9.87M |
|
$-132.06M |
|
$-132.06M |
|
$-132.06M |
|
$-132.06M |
|
$-132.06M |
|
$-132.06M |
|
$-141.93M |
|
$-141.12M |
|
|
Weighted-Average Shares Outstanding (Basic) |
77.30M |
77.30M |
|
$-1.71 |
|
$-1.71 |
|
| Balance Sheet Financials | |
$125.95M |
|
$1.01M |
|
$94.38M |
|
$220.33M |
|
$31.60M |
|
-- |
|
$33.18M |
|
$64.77M |
|
$155.55M |
|
$155.55M |
|
$155.55M |
|
107.85M |
|
| Cash Flow Statement Financials | |
$-20.07M |
|
$-69.77M |
|
$74.54M |
|
$39.88M |
|
$24.57M |
|
$-15.31M |
|
$10.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
17.43% |
|
-758.18% |
|
-758.18% |
|
-753.87% |
|
-705.48% |
|
-705.48% |
|
$-20.20M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
58.87 |
|
6.20 |
|
-84.90% |
|
-84.90% |
|
-59.94% |
|
-84.90% |
|
$1.44 |
|
$-0.26 |
|
$-0.26 |
|